FindTrial
Sign In

Stakeholders facing Ethical Challenges to Develop Guidelines for the use of Surplus Biospecimens

Exploration of Stakeholders facing Ethical Challenges and Develop Guidelines for the use of the Surplus Biospecimens- A Case Series study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/038332
Enrollment
188
Registered
2021-11-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

K Amaresh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Who are involved in clinical trial participants at site. 2. Clinical research stakeholders. 3.Staff members of specimen data management Biorepositories / biobank staff. 4.Pathology department staff in KLE site. 5. North Karnataka region stakeholders like EC members, pathologists, surgeons, biospecimen research staff.

Exclusion criteria

Exclusion criteria: 1.Who comes under the age of 18 years. 2.Vulnerable/ Medically challenged participants.

Design outcomes

Primary

MeasureTime frame
? Identifying and evaluating the challenges faced by the stakeholders in HSB uses in research. ?Develop the HSB Regulatory guidelines, which will be useful for institution and it will improve quality of HSB studies. Timepoint: 2 Year Time period—

Secondary

MeasureTime frame
Research team will be aware of the uses, management, process, handling of surplus human samples. ? Increase the awareness regarding HSB uses and misuses in stakeholders prospective. Timepoint: 2 year Time Period—

Countries

India

Contacts

Public ContactDr Sheetal U Harakuni

KLE college of Pharmacy

msganachari@gmail.com9448634457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026